23:47 , Apr 25, 2019 |  BC Extra  |  Company News

Arch to continue investing in science-driven consumer wellness even as Arivale folds

Four years after raising a $36 million series B round led by Arch Venture Partners and Polaris Partners, scientific wellness company Arivale Inc. (Seattle, Wash.) has shuttered its consumer program, citing troubles with its business...
00:30 , Jul 14, 2016 |  BC Extra  |  Financial News

Polaris targeting $400M for next fund

Polaris Partners is targeting $400 million for Polaris Partners VIII, according to an SEC filing. The firm declined to discuss the new fund. In 2014, Polaris closed its seventh fund at $450 million. It invested...
07:00 , Aug 24, 2015 |  BioCentury  |  Emerging Company Profile

Transforming wellness

Arivale Inc. aims to build a consumer wellness business on top of systems biology work conducted by Lee Hood, using genetics and other personalized data in combination with coaching to improve an individual's health outcomes....
07:00 , Jul 20, 2015 |  BC Week In Review  |  Financial News

Arivale completes venture financing

Arivale Inc. , Seattle, Wash.   Business: Genomics, Supply/Service   Date completed: 2015-07-14   Type: Venture financing   Raised: $36 million   Investors: Arch Venture Partners; Polaris Partners; Maveron  ...
07:00 , Jul 20, 2015 |  BioCentury  |  Finance

On time Arivale

Venture backers of Arivale Inc. say creating a "scientific wellness" company was impossible as recently as five years ago, and that a confluence of biology and consumer appetite justified last week's $36 million series B...
01:07 , Jul 15, 2015 |  BC Extra  |  Financial News

Arivale raises $36M in series B

Arivale Inc. (Seattle, Wash.) raised $36 million in a series B round led by Arch Venture Partners and Polaris Partners. Maveron, which led the company's $3 million series A round in January 2014, also participated....